The lifestyle of naturally occurring CD4+CD25 +Foxp3+ regulatory T cells

Immunological Reviews

Volumn 212, Issue , 2006, Pages 60-73

  Shevach, Ethan M ^a   DiPaolo, Richard A ^a   Andersson, John ^a   Zhao, Dong Mei ^a   Stephens, Geoffrey L ^a   Thornton, Angela M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Autoimmune gastritis; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; GRANZYME B; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; PERFORIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE IMMUNOTHERAPY; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL POPULATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DIABETES MELLITUS; DISEASE COURSE; GASTRITIS; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD4; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; GASTRITIS; HUMANS; MICE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY;

EID: 33746365086     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2006.00415.x     Document Type: Review

References (36)

1. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting IL-2 production. J Exp Med 1998;188:287-296.
2. Picccirillo CA, Shevach EM. Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001;167:1137-1140.
3. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
4. Belkaid Y, Piccirillo CA, Menmdez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502-507.
5. Fahlen L, et al. T cells that cannot respond to TGF-beta escape control by CD4+CD25+ regulatory T cells. J Exp Med 2005;201:737-746.
6. Kullberg MC, et al. TGF-beta 1 production by CD4+CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005;35:2886-2895.
7. Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD4+CD25+ regulatory T cells in vivo. J Exp Med. 2003;198:249-258.
8. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue antigen autoantigen exclusively by dendritic cells in draining lymph node. J Exp Med 2002;196:1079-1090.
9. McHugh RS, Shevach EM, Margulies DH, Natarajan K. A T cell receptor transgenic model of severe spontaneous organ-specific autoimmunity. Eur J Immunol. 2001;31:2094-2103.
10. Candon S, McHugh RS, Foucras G, Natarajan K, Shevach EM, Margulies DH. Spontaneous organ-specific Th2-mediated autoimmunity in TCR transgenic mice. J Immunol 2004;172:2917-2924.
11. DiPaolo RJ, Glass DD, Bijwaard KE, Shevach EM. CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector cells. 2005;175:7135-7142.
12. Sarween N, Chodos A, Raykundalia C, Khan M, Abbas AK, Walker LS. Cd4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation. CXCR-3 expression and tissue invasion. J Immunol. 2004;173:2942-2951.
13. Kohm AP, Carpentier PA, Anger HA, Miller SD. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002;169:4712-4716.
14. Klein L, Khazaie, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 2003;100:8886-8891.
15. Tang Q, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006;7:83-92.
16. Serra P, et al. Cd40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 2003:19:877-889.
17. Chen Z, Hermann AE, Matos M, Mathis D, Benoist C. Where CD4+CD25+ T reg impinge on autoimmune diabetes. J Exp Med 2005;202:1387-1397.
18. Hori S, Haury M, Coutinho A, Demengeot J. Specificity requirements for selection and effector function of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 2002;99:8213-8218.
19. Tang Q, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004;199:1455-1465.
20. Hori S, Nomura R, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.
21. Yagi H, et al. Crucial role of FOXP3 in the development and function of human CD25(+)CD4(+) regulatory T cells. Int Immunol 2004;16:1643-1656.
22. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-336.
23. Chen WJ, et al. Conversion of peripheral CD4+CD25- native T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of the transcription factor Foxp3. J Exp Med 2003;198:1875.1886.
24. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nusenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005;6:1219-1227.
25. Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky AY. Recognition of the peripheral self by naturally arising CD25+CD4+ T cell receptors. Immunity 2004;21:267-277.
26. Stefanova I, Dorfman JR, Germain RN. Self-recognition promotes the foreign antigen sensitivity of naïve T lymphocytes. Nature 2002;420:429-434.
27. Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen non-specific. J Immunol 2000;164:183-190.
28. Thornton AM, Donovan EE, Piccirillo CA, Shevach EM. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 2004;172:6519-6523.
29. McHugh RS, et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-323.
30. Lehman J, et al. Expression of integrin alphaEbeta 7 identifies unique subsets of CD25+ and CD25- regulatory T cells. Proc Natl Acad Sci USA 2002;99:13031-13036.
31. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cells responses. J Exp Med 2003;198:889-901.
32. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM. Control of T cell activation by CD4+CD25+ suppressor T cells. Immunol Rev 2001;182:58-67.
33. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Cutting edge: Contact mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005;174:1783-1786.
34. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001;193:1303-1310.
35. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perform pathway to cause autologous target cell death. Immunity 2004;21:589-601.
36. Zhao DM, Thornton AM, DiPaolo RJ, Shevach EM. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 2006;107:3925-3932.